Recce Pharmaceuticals advances diabetec foot infection trial
Recce Pharmaceuticals (ASX:RCE) received ethical approval to advance its Australian diabetic foot infection trial to a 200-patient Phase 3 study.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Recce Pharmaceuticals (ASX:RCE) received ethical approval to advance its Australian diabetic foot infection trial to a 200-patient Phase 3 study.
Bupa has executed an agreement to acquire Partnered Health Group to grow its integrated healthcare service footprint across Australia.
Cynata Therapeutics (ASX:CYP) announced its Phase 3 trial of CYP-004 showed no statistically significant differences.
Australian Clinical Labs (ASX:ACL) announced it is contacting approximately 280,000 individuals following a cyber incident at its SunDoctors subsidiary.
BCAL Diagnostics (ASX:BDX) has developed a diagnostic blood test that achieved 91% sensitivity for detecting breast cancer recurrence.
Neurizon Therapeutics (ASX:NUZ) executed an agreement with Elanco Animal Health (NYSE:ELAN) to secure a five-year supply of human-health monepantel.
Island Pharmaceuticals (ASX:ILA) secured US FDA Orphan Drug Designation for Galidesivir.
Racura Oncology (ASX:RAC) has raised $34.3 million to fully fund three upcoming clinical trials.
Dimerix (ASX:DXB) executed a licensing agreement with Everest Medicines to develop and commercialise its clinical-stage drug candidate, DMX-200.
Sigma Healthcare (ASX:SIG) has walked away from preliminary discussions to acquire UK health and beauty retailer Boots.
Echo IQ (ASX:EIQ) announced a research collaboration with Mayo Clinic to evaluate its proprietary artificial intelligence platform.
Neurizon Therapeutics (ASX:NUZ) announced that its HEALEY ALS Platform Trial has surpassed the critical 50% dosing milestone.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade